Company

Harbour BioMed's Batoclimab Wins NMPA Marketing Approval in China – First‑Class FcRn Antibody Now Indicated for AChR‑Positive Generalized Myasthenia Gravis
Harbour BioMedHKG: 2142

Harbour BioMed’s Batoclimab Wins NMPA Marketing Approval in China – First‑Class FcRn Antibody Now Indicated for AChR‑Positive Generalized Myasthenia Gravis

Harbour BioMed (HKG: 2142) announced that China's National Medical Products Administration (NMPA) has approved batoclimab for marketing, indicated for the treatment of adult patients with generalized myasthenia gravis (gMG) who…

Merck's Welireg (belzutifan) Wins NMPA Approval in China for Pheochromocytoma and Paraganglioma – Second Chinese Indication for the First‑in‑Class HIF‑2α Inhibitor

Merck’s Welireg (belzutifan) Wins NMPA Approval in China for Pheochromocytoma and Paraganglioma – Second Chinese Indication for the First‑in‑Class HIF‑2α Inhibitor

Novo Nordisk Secures NMPA Indication Update for Wegovy (semaglutide) in China – Expanded Label Now Covers Chinese BMI Criteria for Overweight and Obesity

Novo Nordisk Secures NMPA Indication Update for Wegovy (semaglutide) in China – Expanded Label Now Covers Chinese BMI Criteria for Overweight and Obesity

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Proviva's PTX-912 PD-1 IL-2 Fusion Gets USD 30M Series A+ Boost
CancerFinance

Proviva’s PTX-912 PD-1 IL-2 Fusion Gets USD 30M Series A+ Boost

Pfizer-Astellas' PADCEV Wins FDA Approval for Perioperative Bladder Cancer
ADC / XDCAstellas Pharma

Pfizer-Astellas’ PADCEV Wins FDA Approval for Perioperative Bladder Cancer

GenSci's GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials
Changchun High & New Technology IndustriesClinical trial approval / initiation

GenSci’s GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials

Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR
Generic drugsJiuzhou Pharmaceutical

Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR

Show More